Press Releases Surrozen, Inc.

Equities

SRZN

US86889P2083

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-29 pm EDT			5-day change	1st Jan Change
9.29 ^USD	+3.45%		+0.43%	-1.17%

Apr. 10	Surrozen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 08	Surrozen Insider Bought Shares Worth $2,999,994, According to a Recent SEC Filing	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis	Apr. 03	AQ
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043	Apr. 01	AQ
Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules	Apr. 01	AQ
Surrozen Provides Corporate Update on Clinical Programs	Jan. 18	AQ
Surrozen Provides Third Quarter 2023 Financial Results	Nov. 08	AQ
Surrozen Provides Second Quarter 2023 Financial Results	23-08-09	AQ
Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke	23-06-05	AQ
SURROZEN, INC./DE : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-10	AQ
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates	23-05-10	AQ
SURROZEN, INC./DE : Change in Directors or Principal Officers (form 8-K)	23-04-05	AQ
Surrozen Strengthens Board of Directors with the Appointment of Eric Bjerkholt	23-04-05	AQ
SURROZEN, INC./DE Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-31	AQ
SURROZEN, INC./DE : Other Events (form 8-K)	23-03-23	AQ
Surrozen : Corporate Presentation March 22, 2023	23-03-22	PU
Surrozen Provides Fourth Quarter and Full Year 2022 Financial Results and Update on Clinical Pipeline and Corporate Progress	23-03-22	AQ
Surrozen To Report Fourth Quarter and Full Year 2022 Financial Results and Provide a Corporate Update on March 22, 2023	23-03-20	AQ
Surrozen : Targeted Regeneration Presentation	23-01-12	PU
SURROZEN, INC./DE : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-01-05	AQ
Surrozen to Present at the 41st Annual J.P. Morgan Healthcare Conference	23-01-04	AQ
SURROZEN, INC./DE : Other Events (form 8-K)	22-12-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Surrozen, Inc.

Equities

SRZN

US86889P2083

Press Releases

Filters